Sunshine Lake Pharma's (HKG:6887) controlling shareholder plans to increase his stake by purchasing between HK$300 million and HK$600 million of the company's shares in the open market over the next six months, according to a Monday Hong Kong bourse filing.
The company said Zhang Yushuai currently controls about 294 million shares, representing 51.11% of its issued shares, excluding treasury shares.